Preclinical and clinical studies have demonstrated that GLP-1R activation can augment myocardial blood flow, increase microvascular blood volume, and improve myocardial perfusion reserve, particularly in patients with metabolic syndrome and diabetes, populations at heightened risk for microvascular dysfunction [14]. Here, GLP1R is linked to diabetes mellitus.